GSA Capital Partners’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97K | Buy |
+12,144
| New | +$97K | 0.01% | 1619 |
|
|
2024
Q3 | – | Sell |
-4,582
| Closed | -$112K | – | 1937 |
|
|
2024
Q2 | $112K | Buy |
+4,582
| New | +$112K | 0.01% | 1520 |
|
|
2024
Q1 | – | Sell |
-2,554
| Closed | -$508K | – | 1903 |
|
|
2023
Q4 | $508K | Sell |
2,554
-1,286
| -33% | -$256K | 0.04% | 791 |
|
|
2023
Q3 | $510K | Sell |
3,840
-553
| -13% | -$73.4K | 0.04% | 783 |
|
|
2023
Q2 | $657K | Buy |
4,393
+598
| +16% | +$89.4K | 0.07% | 570 |
|
|
2023
Q1 | $557K | Buy |
+3,795
| New | +$557K | 0.06% | 642 |
|
|
2022
Q4 | – | Sell |
-4,736
| Closed | -$912K | – | 1813 |
|
|
2022
Q3 | $912K | Buy |
4,736
+3,346
| +241% | +$644K | 0.12% | 203 |
|
|
2022
Q2 | $203K | Sell |
1,390
-974
| -41% | -$142K | 0.03% | 1061 |
|
|
2022
Q1 | $416K | Buy |
2,364
+1,266
| +115% | +$223K | 0.06% | 666 |
|
|
2021
Q4 | $323K | Sell |
1,098
-3,080
| -74% | -$906K | 0.04% | 881 |
|
|
2021
Q3 | $1.04M | Buy |
+4,178
| New | +$1.04M | 0.11% | 299 |
|